Literature DB >> 11794574

Stages in the implementation of innovative clinical programs in complex organizations.

R Rosenheck1.   

Abstract

Organizational processes can have an important impact on the introduction of innovative treatments into practice. Conceptual frameworks from organization theory and experiences implementing several hundred specialized mental health programs in the Department of Veterans Affairs (VA) over the past 15 years are used to illustrate stages and processes in the implementation of new treatment models. Four phases in the implementation of new treatments in complex organizational settings are described: a) the decision to implement, b) initial implementation, c) sustained implementation, and d) termination or transformation. Key strategies for moving research into practice include constructing decision-making coalitions, linking new initiatives to legitimate goals and values, quantitative monitoring of implementation and performance, and the development of self-sustaining communities of practice as well as learning organizations. Effective dissemination of new treatment methods requires different organizational strategies at different phases of implementation.

Mesh:

Year:  2001        PMID: 11794574     DOI: 10.1097/00005053-200112000-00002

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN: 0022-3018            Impact factor:   2.254


  10 in total

1.  Program and client characteristics as predictors of the availability of social support services in community-based substance abuse treatment programs.

Authors:  Peter J Delany; Joseph J Shields; Dana L Roberts
Journal:  J Behav Health Serv Res       Date:  2008-12-10       Impact factor: 1.505

2.  Psychopharmacologic Services for Homeless Veterans: Comparing Psychotropic Prescription Fills Among Homeless and Non-Homeless Veterans with Serious Mental Illness.

Authors:  Eric Hermes; Robert Rosenheck
Journal:  Community Ment Health J       Date:  2015-07-23

3.  Implementation of an evidence-based biobehavioral treatment for cancer patients.

Authors:  Marlena M Ryba; Brittany M Brothers; Barbara L Andersen
Journal:  Transl Behav Med       Date:  2017-12       Impact factor: 3.046

4.  Sustaining clinical programs during difficult economic times: a case series from the Hospital Elder Life Program.

Authors:  Gillian K SteelFisher; Lauren A Martin; Sarah L Dowal; Sharon K Inouye
Journal:  J Am Geriatr Soc       Date:  2011-08-29       Impact factor: 5.562

5.  Implementation of consumer providers into mental health intensive case management teams.

Authors:  Alison B Hamilton; Matthew Chinman; Amy N Cohen; Rebecca Shoai Oberman; Alexander S Young
Journal:  J Behav Health Serv Res       Date:  2015-01       Impact factor: 1.505

6.  Identifying factors critical to implementation of integrated mental health services in rural VA community-based outpatient clinics.

Authors:  JoAnn E Kirchner; Marisue Cody; Carol R Thrush; Greer Sullivan; Carla Gene Rapp
Journal:  J Behav Health Serv Res       Date:  2004 Jan-Mar       Impact factor: 1.505

7.  Measuring Use of Research Evidence: The Structured Interview for Evidence Use.

Authors:  Lawrence A Palinkas; Antonio R Garcia; Gregory A Aarons; Megan Finno-Velasquez; Ian W Holloway; Thomas I Mackie; Laurel K Leslie; Patricia Chamberlain
Journal:  Res Soc Work Pract       Date:  2014-12-01

8.  Implementing a continuum of evidence-based psychosocial interventions for people with severe mental illness: part 2-review of critical implementation issues.

Authors:  Catherine Briand; Matthew Menear
Journal:  Can J Psychiatry       Date:  2014-04       Impact factor: 4.356

9.  Knowledge systems, health care teams, and clinical practice: a study of successful change.

Authors:  Curtis A Olson; Tricia R Tooman; Carla J Alvarado
Journal:  Adv Health Sci Educ Theory Pract       Date:  2010-01-13       Impact factor: 3.853

10.  Measuring persistence of implementation: QUERI Series.

Authors:  Candice C Bowman; Elisa J Sobo; Steven M Asch; Allen L Gifford
Journal:  Implement Sci       Date:  2008-04-22       Impact factor: 7.327

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.